Home LiteratureArticle Details
PMID: 3126226 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 140 ·No. 5 ·1988-03-01 ·Pages 1454-60

Monroe JG

Abstract

Control of entry into and progression through the early phases of cell cycle in B lymphocytes is poorly understood at the molecular level. Products of the c-fos proto-oncogene have been implicated in regulation of G0 to G1 cell cycle phase transition and cell proliferation in other systems. In view of these observations, the relationship between signals generated through receptor Ig which alter the B cells position in cell cycle and relative level of c-fos expression was investigated. Not unexpectantly, anti-Ig under conditions which promote G0-G1 and G1-S phase transition was observed to selectively up-regulate expression of c-fos. More interestingly, however, anti-Ig-induced cross-linking of surface Ig on the WEHI-231 B lymphoma also caused rapid and transient up-regulation of c-fos mRNA levels although it was associated with inhibition of proliferation of these cells. These results are important because they show that 1) c-fos expression is inducible in both normal and transformed B lymphocytes as a consequence of signals generated through receptor Ig, and 2) up-regulation of c-fos expression is not positively linked to B cell proliferation but rather appears to be a component of the surface Ig signal transduction mechanism. Finally, studies utilizing phorbol diesters suggest that pathways leading through protein kinase C are involved in both the growth inhibition and c-fos expression WEHI-231 following membrane-associated Ig cross-linking.

MeSH Terms
Animals Antibodies, Anti-Idiotypic/pharmacology B-Lymphocytes/cytology,immunology,metabolism Cell Cycle/drug effects Cell Line Cross-Linking Reagents Growth Inhibitors/pharmacology Interphase/drug effects Lymphocyte Activation/drug effects Mice Proto-Oncogene Proteins/biosynthesis,metabolism Proto-Oncogene Proteins c-fos RNA, Messenger/biosynthesis Receptors, Antigen, B-Cell/metabolism Tetradecanoylphorbol Acetate/pharmacology
Chemicals
Antibodies, Anti-Idiotypic Cross-Linking Reagents Growth Inhibitors Proto-Oncogene Proteins Proto-Oncogene Proteins c-fos RNA, Messenger Receptors, Antigen, B-Cell Tetradecanoylphorbol Acetate
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Monroe J G
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1988-03-01
Pages
1454-60
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI23568 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com